TYSABRI® (natalizumab)

at 225 Binney St., Cambridge , 02142 United States

1. Community
2. Health/Medical/Pharmaceuticals

Description

We hope that this page serves as a resource for U.S. residents affected by and living with relapsing multiple sclerosis, who are already on Tysabri® [natalizumab], or wanting to learn more about TYSABRI. Please visit our page to learn about relapsing multiple sclerosis and possible treatment options, as well as share your stories. Our community managers will work to answer all questions and address comments in a timely manner, but because we exist in a regulated environment, there may be a delay in when your comment appears on the page, as well as responses to questions. All users must comply with Facebook's Terms of Use and our Community Guidelines. This page also adheres to Biogen’s Terms & Conditions https://www.biogen.com/en_us/terms-conditions.html?ID=5452. Please share your story! We encourage users who visit the page to have relevant and helpful conversations about living with relapsing multiple sclerosis. By providing your story for Biogen to use and share online with the Facebook community, you acknowledge and agree that: a) You are solely responsible for the form and content, including the accuracy, of any information provided by you and for any consequences that arise from our sharing your story with our online community, b) Your comments and any information you provide may be abbreviated for purposes of rebroadcasting on Facebook in order to comply with applicable laws, regulations and Biogen policies or for editorial reasons. c) A representative of Biogen may contact you regarding opportunities to publicly discuss or share your story. Please consult Biogen’s Privacy Policy (https://www.biogen.com/en_us/privacy-policy.html) and Terms & Conditions (https://www.biogen.com/en_us/terms-conditions.html) and the Community Guidelines below to understand the rules applicable to your use of the site and any information you share. Comments that violate these Terms of Use will be taken down immediately. As a note, this page is intended for users 18 and over and U.S. audiences only. Community Guidelines: 1. Any comments or conversations that discuss other medical conditions or treatments may be removed from the page. 2. Due to regulations in the healthcare industry, any comments containing a product name and/or mention of multiple sclerosis or MS will be evaluated on an individual basis. Our Facebook page is not intended to compare treatment options, discuss safety issues or report side effects that you’ve experienced while taking Biogen treatments, or any other treatments. If you, or someone you know, has possibly experienced a side effect while taking TYSABRI, please call 1-800-456-2255 to speak to a Biogen Support Coordinator. Should you post about an adverse event with TYSABRI on the TYSABRI Facebook page, Biogen may need to contact you or your healthcare provider to find out more information. If you experience a side effect while using TYSABRI or any other Biogen product, you are encouraged to report it to the FDA. To do so, visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. 3. In order to align with approved Prescribing information in the U.S., comments that fall outside of the U.S. Prescribing Information will be removed from the page. Additionally, any comments that discuss benefits of taking TYSABRI that are not reflected in the Prescribing Information or impact your personal quality of life may be removed. 4. We hope that this page serves as a resource, but do not use information on this page to replace conversations with your doctor. Biogen assumes no responsibility for any user content posted on the page. Do not take the page, or any community comments, as medical advice. Your doctor is always your best source of information when it comes to your health. Likewise, do not post any medical advice or opinions on the page. We reserve the right to remove any comments containing potentially misleading information from the page. 5. Please do not include specific names of healthcare providers, multiple sclerosis treatment centers, or hospitals, as these comments will be removed. 6. In order to protect your privacy, please do not share sensitive personal information including your home or email address, phone number, or zip code on the page. 7. Because each community member may be in a unique situation, all comments discussing financial topics will be evaluated on a case-by-case basis. 8. Be courteous and respectful. Any material considered defamatory or hostile will be removed immediately. Additionally, all comments containing spam will be removed from the page. 9. Please don't use our Facebook page as a place to promote your product or pitch your services. We reserve the right to delete any links to personal products or services that don’t relate to the mission or purpose of the TYSABRI page. 10. For any questions about sponsorships, scholarships, employment, or any other solicitation for services, please refer to the Biogen website rather than posting on this page. 11. All comments containing information about clinical trials that you or someone you care for has participated in will be removed from the page. 12. If a comment does not fall into any of the above categories, but is not consistent with the mission of the community or industry regulations, we reserve the right to remove it. 13. Please check often for updates, as we may change these Community Guidelines at any time.

Company Rating

14011 FB users likes TYSABRI® (natalizumab), set it to 1 position in Likes Rating for Boston, Massachusetts in Community category

Summary

TYSABRI® (natalizumab) is Boston based place and this enity listed in Health/Medical/Pharmaceuticals category. Located at 225 Binney St. MA 02142. Contact phone number of TYSABRI® (natalizumab): (800) 456-2255